Etoposide Capsule
Product Images NDC 83270-451

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 83270-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Onesource Specialty Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Foil (Blister Foil)

Multiple printed labels for Vepesid (Etoposide) Capsules USP 50 mg by Onesource Specialty Pharma Limited. Each label includes the drug name, strength, dosage form, barcodes, and placeholders for lot number and expiration date. The labels are arranged in a sheet format ready for application on packaging.*

FDA Label Image

Carton (Carton)

Packaging label for VePesid (Etoposide Capsules, USP) 50 mg oral capsules. The label indicates the product is supplied as 20 unit dose capsules, contained in 2 blister strips of 10 capsules each. It is labeled for prescription use (Rx only) and includes storage instructions recommending refrigeration between 2°C to 8°C. The labeler/manufacturer is Eirgen Pharma Ltd, Waterford, Ireland.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient etoposide, showing detailed molecular connectivity and arrangement of atoms including oxygen, hydrogen, and carbon with depiction of rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.